In conclusion, bpMRI with CAD (AI) such as ProstatID, is poised to change the Standard of Care for Prostate Cancer screening, detection and diagnosis. 了解更多

New Studies Demonstrate that Bot Image’s Prostate Cancer AI Software Outperforms the Field 了解更多

GE HealthCare’s MIM Software gains FDA clearance for a new Centiloid scaling tool in MIMneuro to quantify amyloid plaque in brain imaging, providing standardized metrics for Alzheimer’s disease evalua 了解更多

MIM Software partners with GenesisCare to enhance global cancer care via advanced imaging and AI solutions. 了解更多